Shandong Bailong Chuangyuan Bio-Tech Co., Ltd. (SHA:605016)

SHA:605016 Revenue

Shandong Bailong Chuangyuan Bio-Tech had revenue of 335.89M CNY in the quarter ending June 30, 2025, with 20.29% growth. This brings the company's revenue in the last twelve months to 1.27B, up 28.64% year-over-year. In the year 2024, Shandong Bailong Chuangyuan Bio-Tech had annual revenue of 1.15B with 32.64% growth.

• Revenue (ttm): 1.27B
• Revenue Growth: +28.64%
• P/S Ratio: 6.64
• Revenue / Employee: 1.28M
• Employees: 988
• Market Cap: 8.43B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.15B	283.39M	32.64%
Dec 31, 2023	868.26M	146.37M	20.28%
Dec 31, 2022	721.89M	68.54M	10.49%
Dec 31, 2021	653.36M	153.73M	30.77%
Dec 31, 2020	499.62M	78.57M	18.66%